Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Januvia
Januvia
IRA negotiations slash Medicare prices for Big Pharma blockbusters by up to 79%
Fierce Pharma
Thu, 08/15/24 - 11:55 am
Medicare
drug pricing
Inflation Reduction Act
JNJ
Xarelto
Imbruvica
Stelara
Bristol Myers Squibb
Eliquis
Eli Lilly
Jardiance
Merck
Januvia
Amgen
Enbrel
AstraZeneca
Farxiga
Novo Nordisk
Fiasp
Novartis
Entresto
Novo Nordisk's Ozempic cuts dementia risk compared with Merck's Januvia: Oxford study
Fierce Pharma
Fri, 07/12/24 - 11:28 am
Novo Nordisk
Ozempic
dementia
Merck
Januvia
Merck, Viatris agree to settle patent feud surrounding diabetes drugs
Endpoints
Mon, 03/20/23 - 04:30 pm
Merck
Viatris
patents
diabetes
Januvia
Janumet
Merck discovers 'root cause' of nitrosamine levels in blockbuster diabetes drugs
Endpoints
Thu, 01/19/23 - 10:20 am
Merck
nitrosamine
diabetes
Januvia
Janumet
drug manufacturing
Merck celebrates another win in Januvia patent battle against Viatris
Endpoints
Sun, 10/2/22 - 07:46 pm
Merck
Januvia
patents
legal
diabetes
Viatris
Merck pulls a patent win for diabetes franchise in West Virginia federal court
Endpoints
Thu, 09/22/22 - 11:12 pm
Merck
Januvia
Janumet
generics
legal
Viatris
FDA says found possible carcinogen in certain samples of Merck's Januvia
Yahoo/Reuters
Tue, 08/9/22 - 11:51 pm
Merck
Januvia
FDA
diabetes
carcinogens
The top 15 blockbuster patent expirations coming this decade
Fierce Pharma
Mon, 07/12/21 - 11:08 am
patents
patent cliff
AbbVie
Humira
Merck
Keytruda
Bristol Myers Squibb
Revlimid
Pfizer
Eliquis
Regeneron
Eylea
JNJ
Stelara
Opdivo
GSK
Dolutegravir
Ibrance
Januvia
Eli Lilly
Trulicity
Novo Nordisk
Victoza
Amgen
Prolia
Xgeva
Novartis
Cosentyx
Takeda
Entyvio
Can a popular class of diabetes drugs that includes Merck's Januvia help treat COVID-19?
Fierce Biotech
Wed, 04/15/20 - 10:52 am
COVID-19
pandemic
Merck
Januvia
diabetes
Boehringer Ingelheim
Eli Lilly
Tradjenta
The top drugs facing cuts under Pelosi's pricing plan
Biopharma Dive
Fri, 09/20/19 - 10:46 pm
drug pricing
Nancy Pelosi
regulatory
Revlimid
Keytruda
Opdivo
Januvia
insulin
Medicare
Novo Nordisk trumpets more Januvia-topping data for oral semaglutide
Fierce Pharma
Fri, 06/29/18 - 10:20 am
Novo Nordisk
semaglutide
Merck
Januvia
HbA1C
Novo Nordisk's oral semaglutide impresses analysts against Victoza, Januvia
Fierce Pharma
Thu, 06/21/18 - 10:58 pm
Novo Nordisk
diabetes
semaglutide
Victoza
Merck
Januvia
Januvia and Janumet: An Update on Merck’s Diabetes Franchise after 2Q17
Market Realist
Fri, 08/25/17 - 09:55 am
Merck
diabetes
Januvia
Janumet
ADA: Merck, Pfizer notch success, but late with SGLT-2 data
BioPharma Dive
Tue, 06/13/17 - 12:15 pm
diabetes
Merck
Pfizer
SGLT2 inhibitor
Januvia
Invokana
Farxiga
Jardiance
Eli Lilly
Boehringer Ingelheim
AstraZeneca
JNJ
Top 10 diabetes drugs by 2016 sales
Fierce Pharma
Thu, 06/8/17 - 10:04 am
diabetes
Sanofi
Novo Nordisk
Eli Lilly
Merck
Lantus
Januvia
Victoza
Levemir
Humalog
Novolog
Invokana
Merck's Diabetes Franchise And The Perils In Proving A Drug's Medical Value
Forbes
Sat, 04/8/17 - 01:09 pm
Merck
diabetes
Januvia
Janumet
Eli Lilly
FDA nixes Merck’s shot at getting Januvia cardio safety data onto the label
Endpoints
Fri, 04/7/17 - 09:54 am
Merck
FDA
Januvia
Januvia, Vaccines May Drive Merck’s Revenue Growth in 2017
Market Realist
Tue, 02/28/17 - 11:52 pm
Merck
Januvia
diabetes
vaccines
Merck Continues to Dominate with Its Januvia Franchise
Market Realist
Thu, 12/29/16 - 10:04 am
Merck
Januvia
diabetes
Merck inks pay-for-performance deal to boost diabetes drugs
BioPharma Dive
Thu, 10/13/16 - 10:33 am
Merck
pay-for-performance
diabetes
Janumet
Januvia
Aetna
Pages
1
2
3
4
5
6
next ›
last »